Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX).
- Disclosed ownership: 2.6%.
- Date of event: 31 Dec 2025.
Point72 Asset Management, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- CLDX
- Shares outstanding
- 67,629,115 shares
- Disclosed Ownership
- 1,758,357 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Mar 2026, 18:41:39 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 10 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 2.6% ownership in Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 10 Jul 2025.
- Current filing was accepted on 10 Mar 2026, 18:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 2.6% | 1,758,357 | 0 | 1,758,357 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 2.6% | 1,758,357 | 0 | 1,758,357 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 2.6% | 1,758,357 | 0 | 1,758,357 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |